Medicine & Health

Researchers at the School of Medicine have received a $5.7 million grant from the National Cancer Institute of the National Institutes of Health (NIH) to investigate immune responses to a cancer-causing virus after organ transplantation in children.

Jaebok Choi, PhD, and Russell Pachynski, MD, both of the School of Medicine, have received Research Scholar Grants from the American Cancer Society to support their research in oncology. Both investigators are research members of Siteman Cancer Center at Barnes-Jewish Hospital and the School of Medicine.

Led by principal investigator David Mutch, MD, researchers at the School of Medicine have received a prestigious Specialized Programs of Research Excellence (SPORE) grant in endometrial cancer from the National Cancer Institute of the National Institutes of Health (NIH).

A new test for two blood cancers — developed by a team at the School of Medicine — is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services.

Led by the School of Medicine and other institutions around the world, the Clinical Proteomic Tumor Analysis Consortium has completed a deep analysis of the proteins driving cancer across multiple tumor types. The findings could help lead to new therapies.

Siteman Cancer Center, based at Barnes-Jewish Hospital and the School of Medicine, has earned a prestigious Merit Extension Award from the National Cancer Institute (NCI), recognizing continued excellence in cancer care, research, training, prevention and community outreach.

A surgical team from the School of Medicine recently performed the first robotic liver transplant in the U.S. in May at Barnes-Jewish Hospital.

Virginia McKay, a research assistant professor at the Brown School, is leading a $3.5 million project to test whether an effort to improve cancer treatment for children in Latin America is sustainable over the long term.

Maggie Mullen, MD, an assistant professor of obstetrics and gynecology at the School of Medicine, has been selected to participate in the National Cancer Institute’s 2023 Early-Stage Surgeon Scientist Program Cohort of Surgeon Scientists.

A new study in mice led by School of Medicine researchers shows how prostate cancer creates its own hormonal fuel supply in response to anti-testosterone therapy. The study further suggests a strategy to block this process and potentially improve therapy options.